• Blog
  • Glucose Monitoring System Market Analysis | 2022-2028

    Glucose Monitoring System Market Analysis | 2022-2028

    Glucose Monitoring System Market Analysis | 2022-2028
    Report code - SR1541 Delivery - 2 Weeks
    Glucose Monitoring System Market Size, Share, Trend, Forecast & Industry Analysis: 202 See more...

    The Glucose Monitoring System Market was estimated at US$ 2.02 billion in 2021 and is expected to grow at a CAGR of 6.19% during 2022-2028 to reach US$ 3.06 billion by 2028.”

    Wish to get a free sample? Register Here

    Market Dynamics

    Introduction

    A Glucose Monitoring System is a medical gadget that helps in managing the amount of glucose in the blood. It usually comprises of a tiny, hand-held, blood glucose testing device, and a series of single-use, easy-touch testing strips. Individuals decide to use a lancet to get a small amount of blood and drip it onto the strip. The meter then devotes the blood sample and offers the numerate value of glucose, most often in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L).

    Some of the most widely used applications include monitoring glucose levels enabling diabetic patients to keep track of their blood sugar levels. The best outcome is that by using this application participants can frequently monitor their consumption of medication and food items as well as physical activities, which enables them to achieve and maintain proper glycemic levels and control the consequences of having diabetes.

    Glucose Monitoring System Market Report Overview

    Market Size in 2028

    USD 3.06 Billion

    Market Size in 2021

    USD 2.02 Billion

    Market Growth (2022-2028)

    6.19%

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

    Market Drivers

    The growth of the glucose monitoring system market is driven by the following factors-

    • An increasing number of people suffering from diabetes driving the growth of the glucose monitoring system market

    • The rising prevalence of chronic disease due to changing lifestyles and unhealthy eating habits is expected to propel market growth significantly.

    • Growing emphasis on research and development activities to develop advanced glucose monitoring systems creating lucrative opportunities for market players.

    Glucose-Monitoring-System-Market-Snapshot

    Want to get more details? Register Here

    COVID-19 Impact

    The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply for a short period and thus affected the market growth.

    Segments Analysis

    Segmentations

    List of Sub-Segments

    Dominant and Fastest-Growing Segments

    End User Type

    Hospitals, Clinics, Home Healthcare

    The hospitals segment accounted for the largest market share and is projected to register significant growth during the forecast period.

    Regional Analysis

    North America, Europe, Asia-Pacific, and Rest of the World

    North America accounted for the largest market share and is projected to grow at a significant CAGR during the forecast period.

    End-User Trends

    The hospitals segment accounted for the largest market share.”

    The glucose monitoring system market has been bifurcated into hospitals, clinics, and home healthcare. Under these, the hospitals segment accounted for the largest market share and is projected to register significant growth during the forecast period. The segment growth can be attributed to the presence of established healthcare infrastructure, technical expertise, and professional healthcare staff.

    Regional Analysis

    North America accounted for the largest market share.”

    North America accounted for the largest market share and is projected to grow at a significant CAGR during the forecast period. The regional growth is primarily attributed to an expanding geriatric populace and rising incidences of diabetes coupled with the presence of key market players such as Echo Therapeutics Inc. (US) and Insulet Corporation (US).

    The market growth in the Asia-Pacific region is expected to be driven by the increasing number of people having diabetes due to a sedentary lifestyle in developing countries, particularly China and India.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The market is highly populated with the presence of several local, regional, and global players. Most of the major players compete in some of the governing factors including price, product offerings, regional presence, etc.  

    The following are the key players in the glucose monitoring system market (arranged alphabetically).

    • Abbott Laboratories (US)
    • AgaMatrix Inc. (Germany)
    • DexCom, Inc. (US)
    • Echo Therapeutics Inc. (US)
    • F. Hoffmann-La Roche AG (Switzerland)
    • Glysure Ltd (UK)
    • Insulet Corporation (US)
    • Johnson & Johnson (US)
    • Medtronic plc (Ireland)
    • ORSENSE LTD (Israel)
    • Senseonics Holdings, Inc. (US)
    • Ypsomed (Switzerland)

    Note: The above list does not necessarily include all the top players in the market.

    Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Glucose Monitoring System Market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast

    Who are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirements?

    10% free customization

    Target Audience

    Here is the list of customers that the glucose monitoring system market hopes to have the greatest opportunity to convert-

    • Glucose Monitoring System Distributors
    • Suppliers
    • Manufacturers
    • Logistics Organizations
    • Government Bodies

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. 

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. 

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players).
    • SWOT analysis of key players (up to 3 players).

    Market Segmentation

    • Current market segmentation of any one of the product types by application type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    A Glucose Monitoring System is a medical device designed to measure and monitor glucose levels in the blood. It typically consists of a small, portable glucose meter and disposable test strips. Users prick their finger to obtain a drop of blood, which is then applied to the test strip. The meter analyzes the blood sample and provides a numerical reading of the glucose concentration, usually displayed in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L).

    The Glucose Monitoring System Market is expected to grow at a CAGR of 6.19% during 2022-2028.

    Medtronic plc (Ireland), Abbott Laboratories (US), DexCom, Inc. (US), Echo Therapeutics Inc. (US), Insulet Corporation (US), Johnson & Johnson (US), Senseonics Holdings, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), AgaMatrix Inc. (Germany), Glysure Ltd (UK), ORSENSE LTD (Israel) and Ypsomed (Switzerland) are among the key players in the market.

    The Glucose Monitoring System Market is expected to reach US$ 3.06 billion by 2028.

    North America accounted for the largest share in the market and will be dominant during the forecast period.

    The hospitals segment is expected to register significant growth in the market in the coming years.